What You Should Know:
Strive Health, a Denver-based provider of value-based kidney care today announced it has raised $166M in Series C funding led by NEA alongside five new investors, including large strategic investor CVS Health Venture.The company will use the new funds to grow and scale the business by expanding into new markets, investing in its existing payor, health system, nephrologist and medical group partnerships and refining its clinical value-based care model. Strive will
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Hyro Secures $20M to Expand Generative/Conversational AI Platform
What You Should Know:
Hyro, the leader in plug-and-play conversational artificial intelligence (AI), today announced that it has finalized a $20 million Series B funding round led by Macquarie Capital, with participation from Liberty Mutual Strategic Ventures, Black Opal Ventures, and existing and new investors, bringing the company’s total funding to $35 million.With this capital raise, Hyro will continue to meet the healthcare sector’s critical demand for conversational AI and automation,
Read More
Why The Evolution of Tech Will be Based on APIs
Layoffs continue to ripple across the economy. Starting with big tech firms and the digital businesses that overhired during the early days of the pandemic, pink slips have now spread to the industrial, manufacturing and professional services industries.
While there are numerous theories on the underlying causes and exacerbators of the surge in job loss, at its core lies a question of efficiency. Companies lay off workers when they believe - rightly or wrongly - that they can accomplish the
Read More
Navigating the Challenges of Biosample Consent in Clinical Trials
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including blood, tissue, saliva, hair, and other bodily fluids. The samples are then analyzed for their genetic, biochemical, or physiological properties, and the findings are used to further the understanding of human health, disease and the environment.
Many times, during clinical trials, sponsors will want to
Read More
It’s Time We Put The Person Back Into Personalized Healthcare
One of the great wonders of life is that every person’s genome is completely unique. Dr. Suess put it best when he wrote: "Today, you are you, that is truer than true. There is no one alive who is youer than you.” As nice as it sounds, this truism presents some serious challenges for healthcare leaders.
The reality that everyone is different makes it incredibly difficult to scale up healthcare systems to meet the unique demands of millions of individuals. In our digital age, the most
Read More
HeartBeam Forms Strategic Alliance with Samsung
What You Should Know:
HeartBeam, a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, announced it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. Under the terms of the strategic alliance, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team's expertise and patented
Read More
Carrum Health Closes $45M Series B to Scale Oncology & Acute Surgical Care
What You Should Know:
Value-based healthcare platform Carrum Health today announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity.The funding will be used to scale the company’s oncology and surgical care service lines for self-insured employers through Carrum Health’s Centers of Excellence network.
Surgery and cancer care have never been better.
Founded in 2014, Carrum Health is a value-based healthcare platform delivering higher quality care
Read More
AI in Drug Discovery Market to Reach $4B by 2027
What You Should Know:
The AI in Drug Discovery market in terms of revenue was estimated to be worth $600M in 2022 and is poised to reach $4B by 2027, growing at a CAGR of 45.7% from 2022 to 2027 according to a new report published by MarketsandMarkets™. The report cites the growing need to curb the drug discovery cost & reduce the overall time taken in this process, the rising adoption of cloud-based applications and services, and the impending patent expiry of blockbuster
Read More
Digital Health Executive Hires: Practice Better Appoints CEO, HHAeXchange, Intelerad, Tegria, Others
Practice Better announced that Kim Walsh will be stepping in as CEO and Nathalie Garcia, Co-Founder of Practice Better, will step into a new role as Chief Strategy Officer where she will continue serving Practice Better’s customers, employees, partners, and investors while supporting and advising Kim in her new role.
HHAeXchange has appointed Paul Joiner as Chief Executive Officer. The new CEO’s appointment also further advances HHAeXchange’s commitment to innovation in its product
Read More
Roundups: 15 Recent Digital Health Strategic Partnerships
Titan Medical Inc. has entered into a license agreement with Intuitive Surgical, Inc., a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (“RAS”), for an upfront payment of $7.5M in respect of certain intellectual property (“IP”) of Titan.
Under the Agreement, Titan has granted Intuitive a non-exclusive license to all of Titan’s IP, with the exception of the IP that is exclusively licensed to another party under a June 2020 license agreement.
Read More
